Endoscopic Submucosal Dissection for Recurrent or Residual Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases
Clinical Endoscopy
;
: 553-557, 2015.
Article
in English
| WPRIM
| ID: wpr-185242
ABSTRACT
We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Recurrence
/
Esophageal Neoplasms
/
Carcinoma, Squamous Cell
/
Follow-Up Studies
/
Endoscopy, Digestive System
/
Chemoradiotherapy
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Clinical Endoscopy
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS